Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. Mai 2024 08:00 ET | Quelle: Optimi Health Corp.

Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules

Optimi Health preparing to export 160 doses of MDMA and psilocybin under Australia’s Authorized Prescriber Scheme.
01. März 2023 07:30 ET | Quelle: Optimi Health Corp.

Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind Medicine Australia Distribution Agreement

Highlights: Signed Purchase Orders with Mind Medicine Australia to ensure that patients with treatment resistant post-traumatic stress disorder (PTSD) have access to medical grade GMP MDMA (using...
06. Februar 2023 08:30 ET | Quelle: Optimi Health Corp.

Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL

The Company is producing OPTI-MHCL in-house under its Health Canada issued Dealers Licence using Optimi’s scalable, proprietary production method. Optimi is also manufacturing MDMA under...